急诊科推注去氧肾上腺素与推注肾上腺素比较
这项回顾性单中心研究纳入2017年5月至2020年11月在急诊科接受推注去氧肾上腺素(PDP-PE,96例)或推注肾上腺素(PDP-E,39例)的成人患者,主要终点为心率变化,次要终点包括血压变化、不良事件、给药错误、液体和血管升压药需求、ICU和住院时间及院内死亡。结果显示两组心率变化中位数分别为0 [-7, 6]次/分和-2 [-15, 5]次/分(p=0.138),PDP-E组收缩压升高幅度更大(33 [24, 53] vs. 26 [8, 51] mmHg,p=0.049),且PDP-E组给药错误更常见(5/39 [12.8%] vs. 2/96 [2.1%],p=0.021)。两组不良事件、液体需求、住院时间或死亡率无差异。作者认为需要更大规模的头对头研究进一步评估PDP-E和PDP-PE的有效性和安全性。
要点
- 急诊科推注肾上腺素(PDP-E)较推注去氧肾上腺素(PDP-PE)收缩压升高幅度更大:中位数33 [24, 53] vs. 26 [8, 51] mmHg(p=0.049)。
- PDP-E组给药错误发生率更高:5/39(12.8%)vs. 2/96(2.1%),p=0.021。
- 两组心率变化中位数无显著差异:PDP-PE组0 [-7, 6]次/分 vs. PDP-E组-2 [-15, 5]次/分(p=0.138)。
- 两组不良事件、液体需求、ICU和住院时间及院内死亡率无差异。
- PDP-E组在推注前后更频繁接受持续肾上腺素输注。
适用人群与场景
- 2017年5月至2020年11月在急诊科接受推注去氧肾上腺素(PDP-PE)或推注肾上腺素(PDP-E)的成人患者。
研究设计与关键结果
- 研究类型:回顾性单中心研究;PDP-PE组96例,PDP-E组39例。
- 主要终点心率变化中位数:PDP-PE组0 [-7, 6]次/分 vs. PDP-E组-2 [-15, 5]次/分(p=0.138)。
- 收缩压升高中位数:PDP-E组33 [24, 53] mmHg vs. PDP-PE组26 [8, 51] mmHg(p=0.049)。
- 给药错误:PDP-E组5/39(12.8%)vs. PDP-PE组2/96(2.1%)(p=0.021)。
- PDP-E组在推注前后更频繁接受持续肾上腺素输注。
- 不良事件、液体需求、ICU和住院时间及院内死亡率无差异。
证据类型、等级与局限
- 证据类型:回顾性单中心研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需要更大规模的头对头研究进一步评估PDP-E和PDP-PE的有效性和安全性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: There is limited evidence to support the efficacy and safety of push-dose vasopressor (PDP) use outside of the operating room (OR). Specifically, there are few head-to-head comparisons of different PDP in these settings. The purpose of this study was to compare the efficacy and safety of push-dose phenylephrine (PDP-PE) and epinephrine (PDP-E) in the Emergency Department (ED).
METHODS: This retrospective, single-center study evaluated adults given PDP-PE or PDP-E in the ED from May 2017 to November 2020. The primary outcome was a change in heart rate (HR). Secondary outcomes included changes in blood pressure, adverse effects, dosing errors, fluid and vasopressor requirements, ICU and hospital lengths of stay (LOS), and in-hospital mortality.
RESULTS: Ninety-six patients were included in the PDP-PE group and 39 patients in the PDP-E group. Median changes in HR were 0 [-7, 6] and - 2 [-15, 5] beats per minute (BPM) for PDP-PE and PDP-E, respectively (p = 0.138). PDP-E patients had a greater median increase in systolic blood pressure (SBP) (33 [24, 53] vs. 26 [8, 51] mmHg; p = 0.049). Dosing errors occurred more frequently in patients that received PDP-E (5/39 [12.8%] vs. 2/96 [2.1%]; p = 0.021). PDP-E patients more frequently received continuous epinephrine infusions before and after receiving PDP-E. There were no differences in adverse effects, fluid requirements, LOS, or mortality.
CONCLUSION: PDP-E provided a greater increase in SBP compared to PDP-PE. However, dosing errors occurred more frequently in those receiving PDP-E. Larger head-to-head studies are necessary to further evaluate the efficacy and safety of PDP-E and PDP-PE.
参考来源
- Nam E, Fitter S, Moussavi K, et al. Comparison of push-dose phenylephrine and epinephrine in the emergency department. Am J Emerg Med. 2021. PMID: 34864289. doi:10.1016/j.ajem.2021.11.033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。